home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 28, 2016
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 683 active entries

LEUKOCARE AG

Am Klopferspitz 19
Martinsried/Munich, 82152
Germany

Phone:  +49-(0)89- 780
Fax: +49-(0)89- 780 16&
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

LEUKOCARE provides a next-generation formulation technology platform for the protection of proteins like biopharmaceuticals to allow the development of better products. The proprietary Stabilizing and Protecting Solutions (SPS®) technologies are provided to development projects of partners in the pharmaceutical and medical device industry. As different stakeholders have different needs, the SPS® platform is separated into the following three main pillars:

- improvement of thermal stability

- protection during sterilization

- functionalization of medical devices

LEUKOCARE's SPS® technologies improve stability and quality of biologics like antibodies, vaccines etc. in dry and liquid formulation and protect proteins in biologically functionalized medical devices like implants, wound dressings, microneedles etc. during sterilization.

Beyond, LEUKOCARE supports its partners with related services and know how in order to evaluate and to implement the SPS® technologies in the partnered products:

- Establishment of accelerated aging models for stability testing

- Development of customized lyophilization protocols

- Development of spray drying and spray freeze drying processes

- Coupling of biological compounds to functionalize surfaces of medical devices

- Conduction of analytics and establishment of biological read outs

 

LEUKOCARE’s research and development activities are based on its well established quality management system (QM) according to EN ISO 9001 and EN ISO 13485.



Selected Categories:
Product Company   Service Company
Contract
- Research
- Services

Last update of this entry: November 28, 2014

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.